周三,William Blair分析师将Charles River Laboratories International Inc.(纽约证券交易所代码:CRL)的股票评级从"跑赢大市"下调至"市场表现"。这一决定是在对公司近期前景日益担忧的背景下做出的,目前该股票交易价格接近其52周低点160.84美元。
William Blair downgraded Charles River Laboratories to market perform citing concerns over a decline in early-stage R&D funding from large pharmas. Read more here.
Upslope Capital Management highlighted stocks like Charles River Laboratories International, Inc. (NYSE:CRL) in the fourth quarter 2024 investor letter. Charles River Laboratories International ...
which analysts estimate could create an incremental headwind to Charles River Labs (NYSE:CRL)' 2025 EPS in the range of $1.00 to $1.30. This represents approximately 10% to 14% of the analysts ...